Endocannabinoid signaling regulates a host of physiological processes throughout the body. In the brain, endocannabinoids regulate mood, memory, appetite, pain levels, and reward. Endocannabinoids also regulate insulin release and resistance along with a variety of gastrointestinal processes including gastric emptying and motility. Phytecs researchers are investigating endocannabinoid system function in metabolic disorders ranging from obesity to schizophrenia, many of which have been poorly managed by existing treatments.
Endocannabinoid stimulation is how the body “regulates regulation” for a host of physiological processes. From immune response to motor function to digestion, endocannabinoids help balance and mediate how the human body functions. Maintaining optimal endocannabinoid function is greatly helped by healthy lifestyle choices from exercise and yoga to a diet rich in the healthy fats such as omega-3s that the body uses to make endocannabinoids. Phytecs is developing a broad suite of products to maintain and restore endocannabinoid health.
With healthcare costs increasing, policy makers should recognize the role of the endocannabinoid system in maintaining health, not simply in treating illnesses. Phytecs is committed to research and development that ensures such health. Phytecs advises lawmakers on developing initiatives that incorporate our broad knowledge base to increase public health.
Phytecs partners with leaders in pharmaceuticals, nutritional supplements and cosmetics to bring innovations to markets throughout the world. With metabolic disease rates skyrocketing in industrialized societies, Phytecs interventions to treat disorders such as diabetes and obesity create new opportunities for our partners.
ECS Stimulation by Artwork by John Karapelou, Text by Phytecs is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License